Antibodies proposed as therapeutic agents.
Bismuth
C
C
Hôpital Fernand Widal, Paris, France.
Baud
F J
FJ
Borron
S W
SW
Scherrmann
J M
JM
D000906:Antibodies / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000276:immunology / Q000627:therapeutic use; D000997:Antivenins / Q000276:immunology / Q000627:therapeutic use; D003078:Colchicine / Q000276:immunology; D004070:Digitalis / Q000276:immunology; D004731:Endotoxins / Q000276:immunology; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D007167:Immunotherapy / Q000639:trends*; D010946:Plants, Medicinal; D010947:Plants, Toxic; D014118:Toxins, Biological / Q000276:immunology*
D000906:Antibodies; D000911:Antibodies, Monoclonal; D000929:Antidepressive Agents, Tricyclic; D000997:Antivenins; D004731:Endotoxins; D007140:Immunoglobulin Fab Fragments; D014118:Toxins, Biological; D003078:Colchicine